AAIC 2024: Cell-Based Therapeutic Approach Shows Potential for Improvement in Alzheimer Disease
Results from the CLEAR MIND trial show Lomecel-B improved cognitive function, quality of life, and brain volume in the treatment of mild Alzheimer disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.